세계의 감염 예방 시장 보고서(2025년)

Infection prevention encompasses a range of measures and practices aimed at reducing the risk and spread of infectious diseases. These practices include hygiene measures such as regular hand washing, vaccination, and the use of protective equipment. They play a critical role in healthcare settings, public spaces, and personal care to safeguard both individual and public health.

The key product categories within infection prevention include sterilization equipment, disinfectors, and consumables. Sterilization equipment is used to eliminate all forms of microbial life, including bacteria, viruses, and spores, from surfaces, fluids, medications, or biological culture media. Various types of infections, including microbial and healthcare-associated infections, are targeted by these products. They are utilized by a range of end-users such as hospitals and clinics, pharmaceutical companies, clinical laboratories, medical device companies, the life science industry, and academic and research centers.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The infection prevention market research report is one of a series of new reports from The Business Research Company that provides infection prevention market statistics, including infection prevention industry global market size, regional shares, competitors with an infection prevention market share, detailed infection prevention market segments, market trends, and opportunities, and any further data you may need to thrive in the infection prevention industry. This infection prevention market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The infection prevention market size has grown steadily in recent years. It will grow from $43.4 billion in 2024 to $44.87 billion in 2025 at a compound annual growth rate (CAGR) of 3.4%. The growth in the historic period can be attributed to increasing awareness of healthcare-associated infections (HAIS), stringent regulatory guidelines, advancements in technology, globalization and international travel, and rising healthcare expenditure.

The infection prevention market size is expected to see steady growth in the next few years. It will grow to $51.91 billion in 2029 at a compound annual growth rate (CAGR) of 3.7%. The growth in the forecast period can be attributed to emerging infectious diseases, technological innovations, global population growth, and rise in ambulatory care services. Major trends in the forecast period include telemedicine and digital health solutions, personalized infection prevention, increased use of artificial intelligence (AI), rapid diagnostics, and focus on behavioral interventions.

The forecast of 3.7% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Trade tensions could hinder U.S. hospital safety measures by inflating prices of single-use sterile barriers and chlorhexidine solutions developed in France and Brazil, resulting in higher surgical site infection rates and increased post-operative care costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increase in the incidence of hospital-acquired infections (HAIs) is expected to fuel the growth of the infection prevention market going forward. HAIs refer to infections that patients acquire while receiving healthcare treatment in a hospital or other healthcare facility. Infection prevention strategies are crucial in addressing these infections by implementing measures designed to minimize the risk of infections and enhance patient safety. For instance, according to the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, data from the third Point Prevalence Survey (PPS) of HAIs in 2022-2023 revealed that an estimated 4.3 million patients in EU/EEA hospitals acquire at least one HAI each year. As the incidence of HAIs continues to rise, the demand for infection prevention solutions is driving market growth.

Key players in the infection prevention market are innovating by developing new products such as infection preventionist staffing calculators to enhance their service offerings. These calculators help estimate the required number of infection preventionists in a healthcare facility based on factors such as bed count, patient acuity, and facility type. For example, the Association for Professionals in Infection Control and Epidemiology (APIC) launched an infection preventionist staffing calculator in December 2023. This tool aids hospitals and clinics in determining the appropriate number of infection preventionists (IPs) needed, thereby improving patient safety through optimal staffing levels. Continuous refinement of the calculator using data from healthcare facilities ensures accurate staffing recommendations.

In January 2023, Applied UV, Inc., a US-based disinfection technology company, acquired Puro Lighting for an undisclosed amount. This acquisition allows Applied UV to leverage Puro Lighting's established commercial relationships, including partnerships with major companies such as Acuity Brands, Ushio, and Johnson Controls. Puro Lighting, a US-based medical equipment manufacturing company, specializes in UV light disinfection technologies. This strategic acquisition strengthens Applied UV's position in the disinfection market, particularly in healthcare and commercial applications, enhancing its capabilities in advanced disinfection solutions.

Major companies operating in the infection prevention market report are Cardinal Health Inc., 3M Company, Stryker Corporation, Reckitt Benckiser Group plc, Ecolab Inc., B. Braun Melsungen AG, The Clorox Company, Olympus Corporation, Fortive Corporation, Steris PLC, Genitge AB, Sotera Health Inc., Belimed AG, Coltene Group, Steelco S.p.A., Skytron LLC, Melag Medizintechnik GmbH & Co. KG, Metrex Research, Pal International, Cisa Production S.r.l. Unipersonale, Covalon Technologies Ltd., Biosafe Systems LLC, Terragene SA, Micro-Scientific LLC, Matachana SA

North America was the largest region in the infection prevention market in 2024. The regions covered in the infection prevention market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the infection prevention market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The infection prevention market consists of revenues earned by entities by providing services such as disinfection, sterilization, and isolation precautions. The market value includes the value of related goods sold by the service provider or included within the service offering. The infection prevention market consists of sales of hand hygiene products, personal protective equipment (PPE), antimicrobial wipes and sprays, sharps disposal containers, and biohazard bags. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Infection Prevention Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on infection prevention market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for infection prevention ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The infection prevention market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Sterilization Equipment; Disinfectors; Consumables
• 2) By Infection Type: Microbial Infections; Healthcare Associated Infections
• 3) By End User: Hospitals And Clinics; Pharmaceutical Companies; Clinical Laboratories; Medical Device Companies; Life Science Industry; Academic And Research Center
• Subsegments:
• 1) By Sterilization Equipment: Steam Sterilizers; Ethylene Oxide Sterilizers; Plasma Sterilizers; Dry Heat Sterilizers; Chemical Sterilizers
• 2) By Disinfectors: Surface Disinfectors; Endoscope Disinfectors; Washer Disinfectors; Automated Disinfecting Systems
• 3) By Consumables: Sterilization Pouches And Wraps; Disinfectant Wipes; Chemical Indicators; Personal Protective Equipment (PPE); Cleaning Agents And Solutions
• Companies Mentioned: Cardinal Health Inc.; 3M Company; Stryker Corporation; Reckitt Benckiser Group plc; Ecolab Inc.; B. Braun Melsungen AG; The Clorox Company; Olympus Corporation; Fortive Corporation; Steris PLC; Genitge AB; Sotera Health Inc.; Belimed AG; Coltene Group; Steelco S.p.A.; Skytron LLC; Melag Medizintechnik GmbH & Co. KG; Metrex Research; Pal International; Cisa Production S.r.l. Unipersonale; Covalon Technologies Ltd.; Biosafe Systems LLC; Terragene SA; Micro-Scientific LLC; Matachana SA
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Infection Prevention Market Characteristics

3. Infection Prevention Market Trends And Strategies

4. Infection Prevention Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Infection Prevention Growth Analysis And Strategic Analysis Framework

• 5.1. Global Infection Prevention PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Infection Prevention Market Growth Rate Analysis
• 5.4. Global Infection Prevention Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Infection Prevention Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Infection Prevention Total Addressable Market (TAM)

6. Infection Prevention Market Segmentation

• 6.1. Global Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sterilization Equipment
• Disinfectors
• Consumables
• 6.2. Global Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Microbial Infections
• Healthcare Associated Infections
• 6.3. Global Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals And Clinics
• Pharmaceutical Companies
• Clinical Laboratories
• Medical Device Companies
• Life Science Industry
• Academic And Research Center
• 6.4. Global Infection Prevention Market, Sub-Segmentation Of Sterilization Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Steam Sterilizers
• Ethylene Oxide Sterilizers
• Plasma Sterilizers
• Dry Heat Sterilizers
• Chemical Sterilizers
• 6.5. Global Infection Prevention Market, Sub-Segmentation Of Disinfectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surface Disinfectors
• Endoscope Disinfectors
• Washer Disinfectors
• Automated Disinfecting Systems
• 6.6. Global Infection Prevention Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Sterilization Pouches And Wraps
• Disinfectant Wipes
• Chemical Indicators
• Personal Protective Equipment (PPE)
• Cleaning Agents And Solutions

7. Infection Prevention Market Regional And Country Analysis

• 7.1. Global Infection Prevention Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Infection Prevention Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Infection Prevention Market

• 8.1. Asia-Pacific Infection Prevention Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Infection Prevention Market

• 9.1. China Infection Prevention Market Overview
• 9.2. China Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Infection Prevention Market

• 10.1. India Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Infection Prevention Market

• 11.1. Japan Infection Prevention Market Overview
• 11.2. Japan Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Infection Prevention Market

• 12.1. Australia Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Infection Prevention Market

• 13.1. Indonesia Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Infection Prevention Market

• 14.1. South Korea Infection Prevention Market Overview
• 14.2. South Korea Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Infection Prevention Market

• 15.1. Western Europe Infection Prevention Market Overview
• 15.2. Western Europe Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Infection Prevention Market

• 16.1. UK Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Infection Prevention Market

• 17.1. Germany Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Infection Prevention Market

• 18.1. France Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Infection Prevention Market

• 19.1. Italy Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Infection Prevention Market

• 20.1. Spain Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Infection Prevention Market

• 21.1. Eastern Europe Infection Prevention Market Overview
• 21.2. Eastern Europe Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Infection Prevention Market

• 22.1. Russia Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Infection Prevention Market

• 23.1. North America Infection Prevention Market Overview
• 23.2. North America Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Infection Prevention Market

• 24.1. USA Infection Prevention Market Overview
• 24.2. USA Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Infection Prevention Market

• 25.1. Canada Infection Prevention Market Overview
• 25.2. Canada Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Infection Prevention Market

• 26.1. South America Infection Prevention Market Overview
• 26.2. South America Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Infection Prevention Market

• 27.1. Brazil Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Infection Prevention Market

• 28.1. Middle East Infection Prevention Market Overview
• 28.2. Middle East Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Infection Prevention Market

• 29.1. Africa Infection Prevention Market Overview
• 29.2. Africa Infection Prevention Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Infection Prevention Market, Segmentation By Infection Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Infection Prevention Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Infection Prevention Market Competitive Landscape And Company Profiles

• 30.1. Infection Prevention Market Competitive Landscape
• 30.2. Infection Prevention Market Company Profiles
  • 30.2.1. Cardinal Health Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. 3M Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Reckitt Benckiser Group plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Ecolab Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Infection Prevention Market Other Major And Innovative Companies

• 31.1. B. Braun Melsungen AG
• 31.2. The Clorox Company
• 31.3. Olympus Corporation
• 31.4. Fortive Corporation
• 31.5. Steris PLC
• 31.6. Genitge AB
• 31.7. Sotera Health Inc.
• 31.8. Belimed AG
• 31.9. Coltene Group
• 31.10. Steelco S.p.A.
• 31.11. Skytron LLC
• 31.12. Melag Medizintechnik GmbH & Co. KG
• 31.13. Metrex Research
• 31.14. Pal International
• 31.15. Cisa Production S.r.l. Unipersonale

32. Global Infection Prevention Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Infection Prevention Market

34. Recent Developments In The Infection Prevention Market

35. Infection Prevention Market High Potential Countries, Segments and Strategies

• 35.1 Infection Prevention Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Infection Prevention Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Infection Prevention Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer